Rocket Pharmaceuticals, a stealthy gene therapy startup in New York City, has made its first splash. Through a merger with struggling Inotek Pharmaceuticals (NASDAQ: ITEK), Rocket, a company developing treatments for a variety of rare blood diseases, has taken itself public. Rocket shareholders are expected to own 81 percent of the combined company, with Inotek […]
NYS Entity Status
NYS Filing Date
OCTOBER 24, 2013
NYS DOS ID#
NYS Entity Type
DOMESTIC PROFESSIONAL CORPORATION
2013 - NEW YORK CARE PHYSICAL THERAPY P.C.
Around the Web
- Stealthy NY Startup Rocket Pharma Merges With Inotek, Heads to Nasdaq
By Ben Fidler - Tuesday Sep 12, 2017
- The Rebuilding Years, Post-Sandy
By THE NEW YORK TIMES and JONAH MARKOWITZ - Sunday Oct 29, 2017
Those affected by Hurricane Sandy five years ago shared how the storm changed their lives physically, emotionally and financially, and how things have changed for the better since.
- Health plan failure brings dread for Obamacare beneficiaries
By JAMES ANDERSON and CARLA K. JOHNSON, Associated Press - Wednesday Jul 19, 2017
[...] while Republicans in Congress failed this week to craft a new health care plan, they did succeed in shaking the confidence of those who rely on the act the most.Alison Chandra sobbed with relief Monday night when she heard that the Republican health care plan appeared doomed.[...] Chandra's anxiety swept back when she heard about the GOP effort to repeal the health plan with no replacement.Dawn Erin went to her first round of physical therapy Tuesday to treat painful bladder infections she's suffered for two decades.Physical therapy might seem mundane for some, but the 46-year-old from Austin, Texas, was ecstatic.Erin relies on a government subsidy to help pay for her plan.Alexandra Flores, 29, a library assistant at the University of South Florida in St. Petersburg, was astonished with Trump's "Let Obamacare fail" declaration and his further insistence that "I'm not going to own it."Trump is acting like those who currently benefit from the ACA are wrong and will be punished for the simple act of having health insurance," Flores said, adding that she feels he's using her health care coverage "as a bargaining chip.Potter was covered under the Affordable Care Act when she unexpectedly became pregnant last year and had bleeding and other complications.AP writers Kelli Kennedy in Fort Lauderdale, Florida; Collin Binkley in Boston; Holly Ramer in Concord, New Hampshire; Lindsey Whitehurst in Salt Lake City and Margery Beck in Omaha, Nebraska, also contributed to this report.
- FDA Refuses to Review Acorda Parkinson’s Drug, Shares Tumble
By Ben Fidler - Tuesday Aug 29, 2017
The heat is on Acorda Therapeutics once again. Months after Acorda lost a key group of patents, the FDA has declined to review, at least for now, an experimental Parkinson’s disease drug that is critical to the company’s future. Acorda (NASDAQ: ACOR) said this morning that the FDA has sent the Ardsley, NY, company a […]
- Acorda Scraps One Parkinson’s Drug, Puts Its Cash Behind Another
By Frank Vinluan - Monday Nov 20, 2017
Acorda Therapeutics said Monday that it will stop work on an experimental treatment for Parkinson’s disease, spelling the end for a drug the Ardsley, NY, company added to its pipeline last year in a $363 million deal. The announcement follows the recent emergence of safety problems for the Acorda (NASDAQ: ACOR) drug, tozadenant. Acorda said […]